Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.

Affiliation

Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA; UPMC Hillman Cancer Center, Pittsburgh, PA. Electronic address: [Email]

Abstract

Of women diagnosed with metastatic breast cancer (MBC), 20% to 30% survive ≥5 years. We evaluated data from a large breast cancer program to identify features associated with MBC survival.

Keywords

Epidemiology,Hormonal therapy,Metastatic breast cancer,Prognostic factors,Survival,